Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
1 other identifier
observational
240
1 country
1
Brief Summary
The Psychosocial Assessment Tool (PAT) is an international used instrument for the screening for psychosocial risk factors in families of a child with cancer. This study want to investigate the validation and evaluation of the clinical value of the Flemish translation of the psychosocial assessment tool
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2017
CompletedFirst Posted
Study publicly available on registry
August 7, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2022
CompletedJuly 3, 2024
July 1, 2024
5 years
July 28, 2017
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
validation of PAT questionnaire
The PAT validation will be performed by correlating PAT scores with validated questionnaires measuring similar constructs as the PAT. These questionnaires are Inventory social reliance, strengths and difficulties questionnaire , hospital anxiety and depression scale, parenting stress index -short version and illness cognition questionnaire parent version.
baseline assessment at diagnosis
Secondary Outcomes (1)
clinical value of questionnaire
baseline assessment at diagnosis
Study Arms (1)
parents children pediatric cancer
Screening questionnaire psychosocial risk factors
Interventions
Eligibility Criteria
parents of all children and adolescents from 0-18 years that are diagnosed with cancer
You may qualify if:
- parents of all children and adolescents from 0-18 years that are diagnosed with cancer
You may not qualify if:
- no knowledge of Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jurgen Lemiere, PhD
UZ Leuven
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2017
First Posted
August 7, 2017
Study Start
September 1, 2017
Primary Completion
September 8, 2022
Study Completion
September 8, 2022
Last Updated
July 3, 2024
Record last verified: 2024-07